- Researchers are preparing for clinical trials examining whether high doses of vitamin C, administered intravenously, can slow the spread of non-Hodgkin's lymphoma.
Thomas Jefferson University Hospital and Jefferson's Kimmel Cancer Center, along with the National Institutes of Health, plan to begin enrollment within the next few weeks of 20 non-Hodgkin's lymphoma patients who have failed standard therapy.
Each study participant will be given varied intravenous doses of vitamin C three times a week during the study, expected to last from 4 to 6 months, the hospital said Wednesday.
"This is a very unique study for a set of patients who have really run out of options," said Dr. Daniel Monti, director of Jefferson's Myrna Brind Center of Integrative Medicine and study's lead investigator
http://www.wtop.com/?nid=106&sid=1319657Well, I will be interested to hear about the results for this. These people are desperate and at least this is unlikely to hurt them. So, woos, want to still talk about how NOBODY does scientific studies on your pet projects?